Costs associated with Alzheimer's disease in Italy: baseline results from the GERAS II observational study

被引：0

作者：

Bruti, G. ^{[1
]}

Bruno, G. ^{[2
]}

Mancini, M. ^{[1
]}

Reed, C. ^{[3
]}

机构：

[1] Eli Lilly Italy, Global Patient Safety Neurosci, Florence, Italy

[2] Univ Rome, Dept Neurol & Psychiat, Rome, Italy

[3] Eli Lilly & Co Ltd, Global Patient Outcomes & Real World Evidence, Windlesham, Surrey, England

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2016年 / 52卷

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S61 / S62

页数：2

共 50 条

[31] Monetary costs of Alzheimer’s disease in China: protocol for a cluster-randomised observational study
Fangyu Li
Shuoqi Chen
Cuibai Wei
Jianping Jia
BMC Neurology, 17
[32] EXCESS COSTS ASSOCIATED WITH POSSIBLE MISDIAGNOSIS OF ALZHEIMER'S DISEASE AMONG PATIENTS WITH VASCULAR DEMENTIA IN ITALY
Barrett, A.
Belger, M.
Dell'Agnello, G.
Mancini, M.
Reed, C.
Sangiori, D.
Blini, V
Buda, S.
Esposti, L. D.
Happich, M.
VALUE IN HEALTH, 2015, 18 (07) : A753 - A753
[33] Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study
Lenox-Smith, Alan
Reed, Catherine
Lebrec, Jeremie
Belger, Mark
Jones, Roy W.
BMC GERIATRICS, 2018, 18
[34] Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease - Results from the GALATEA multicentre, observational study
Gil, Pedro
Dobato Ayuso, Jose Luis
Manuel Marey, Jose
Anton, Manuel
Guzman Quilo, Carlos
CLINICAL DRUG INVESTIGATION, 2008, 28 (07) : 429 - 437
[35] Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS
Reed, Catherine
Belger, Mark
Scott Andrews, J.
Tockhorn-Heidenreich, Antje
Jones, Roy W.
Wimo, Anders
Dodel, Richard
Haro, Josep Maria
INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 (02) : 267 - 277
[36] COMPARING RESOURCE USE IN ALZHEIMER'S DISEASE ACROSS THREE EUROPEAN COUNTRIES-18-MONTH RESULTS OF THE GERAS STUDY
Belger, M.
Arigmon, J. M.
Dodel, R.
Haro, J. M.
Wimo, A.
Reed, C.
VALUE IN HEALTH, 2015, 18 (07) : A759 - A760
[37] Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
Frank Jessen
Annika Spottke
Henning Boecker
Frederic Brosseron
Katharina Buerger
Cihan Catak
Klaus Fliessbach
Christiana Franke
Manuel Fuentes
Michael T. Heneka
Daniel Janowitz
Ingo Kilimann
Christoph Laske
Felix Menne
Peter Nestor
Oliver Peters
Josef Priller
Verena Pross
Alfredo Ramirez
Anja Schneider
Oliver Speck
Eike Jakob Spruth
Stefan Teipel
Ruth Vukovich
Christine Westerteicher
Jens Wiltfang
Steffen Wolfsgruber
Michael Wagner
Emrah Düzel
Alzheimer's Research & Therapy, 10
[38] Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE)
Jessen, Frank
Spottke, Annika
Boecker, Henning
Brosseron, Frederic
Buerger, Katharina
Catak, Cihan
Fliessbach, Klaus
Franke, Christiana
Fuentes, Manuel
Heneka, Michael T.
Janowitz, Daniel
Kilimann, Ingo
Laske, Christoph
Menne, Felix
Nestor, Peter
Peters, Oliver
Priller, Josef
Pross, Verena
Ramirez, Alfredo
Schneider, Anja
Speck, Oliver
Spruth, Eike Jakob
Teipel, Stefan
Vukovich, Ruth
Westerteicher, Christine
Wiltfang, Jens
Wolfsgruber, Steffen
Wagner, Michael
Duezel, Emrah
ALZHEIMERS RESEARCH & THERAPY, 2018, 10
[39] Comorbidities of Alzheimer's disease - results of a multicentric observational COSMOS study in the Slovak Republic
Minar, M.
Dragasek, J.
Mateffy, I
Valkovic, P.
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 95 - 99
[40] Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)
Robinson, Rebecca L.
Rentz, Dorene M.
Andrews, Jeffrey Scott
Zagar, Anthony
Kim, Yongin
Bruemmer, Valerie
Schwartz, Ronald L.
Ye, Wenyu
Fillit, Howard M.
JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 437 - 450

← 1 2 3 4 5 →